ATBECHDEDKESFR..GRITLILUNLSEMCPTIESI....FI....CY....................................................JJDIM360 Ver 1.28 (29 Oct 2014) - 2999001/0enThis application was filed on 30 - 03 - 2006 as a divisional application to the application mentioned under INID code 62.1674107CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120170125W173deBibliographieenBibliographyfrBibliographieEP06006697.4199909242006033020150722enenen101828 P19980925US125750 P19990324US2017012520170420060628200626201608242016342016071320170125201704A61K 38/12 20060101AFI20160620BHEP A61P 31/04 20060101ALI20160620BHEP deVerwendung von DaptomycinenUse of daptomycinfrUtilisation de daptomycinEP-A- 0 386 951WO-A-98/22107WO-A-99/30728J.R. WOODWORTH ET AL.: "SINGLE-DOSE PHARMACOKINETICS AND ANTIBACTERIAL ACTIVITY OF DAPTOMYCIN, A NEW LIPOPEPTIDE ANTIBIOTIC, IN HEALTHY VOLUNTEERS.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 36, no. 2, February 1992 (1992-02), pages 318-325, XP000891776, BETHESDA, USJ.R. WOODWORTH ET AL.: "TOBRAMYCIN AND DAPTOMYCIN DISPOSITION WHEN CO-ADMINISTERED TO HEALTHY VOLUNTEERS", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 33, no. 3, March 1994 (1994-03), pages 655-659, XP000891828, LONDON, GBE. BERNARD ET AL.: "PHARMACOKINETICS AND SUCTION BLISTER FLUID PENETRATION OF A SEMISYNTHETIC INJECTABLE STREPTOGRAMIN RP 59500 (RP 57669/RP 54476)", EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES,DE,WIESBADEN, vol. 13, no. 9, 1 September 1994 (1994-09-01), pages 768-771, XP002037989,F.P. TALLY ET AL.: "DAPTOMYCIN: A NOVEL AGENT FOR GRAM-POSITIVE INFECTIONS.", EXPERT OPINION ON INVESTIGATIONAL DRUGS, vol. 8, no. 8, August 1999 (1999-08), pages 1223-1228, XP000891801, LONDON, GBR.C. MOELLERING ET AL.: "THE EFFICACY AND SAFETY OF QUINUPRISTIN/DALFOPRISTIN FOR THE TREATMENT OF INFECTIONS CAUSED BY VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM.", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 44, no. 2, August 1999 (1999-08), pages 251-261, XP000891830, london, gbKENNEDY S ET AL: "Daptomycin (LY146032) for prevention and treatment of experimental aortic valve endocarditis in rabbits.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY SEP 1989 LNKD- PUBMED:2554799, vol. 33, no. 9, September 1989 (1989-09), pages 1522-1525, XP009159386, ISSN: 0066-4804OLESON F B ET AL: "ONCE-DAILY DOSING DECREASES TOXICITY OF DAPTOMYCIN", TOXICOLOGICAL SCIENCES, ACADEMIC PRESS, vol. 48, 1 January 1999 (1999-01-01), page 322, XP009039198, ISSN: 1096-6080RICHARD H. BALTZ: 'Lipopeptide antibiotics produced by Streptomyces roseosporus and Streptomyces fradiae' 01 January 1997, pages 415 - 435, XP055201803N.N.: "Cubist starts pivotal trials with daptomycin", Scrip Newsletter, 10 March 1999 (1999-03-10), XP055201798, [retrieved on 2015-07-13]N.N.: "Cubist pharmaceuticals initiates pivotal clinical trials for Daptomycin; novel antiinfective to treat serious life threatening infections.", , 1 March 1999 (1999-03-01), XP055201792, [retrieved on 2015-07-13]99949913.0111541719990924Oleson, Frederick B. Jr.5 Partridge LaneConcord, MA01742USTally, Francis P.336 Hemlock CircleLincoln, MA 01733USCubist Pharmaceuticals LLC101632270P060556EP.BRCWeystrasse 206000 Lucerne 6CHCarpmaels & Ransford LLP101299776One Southampton RowLondon WC1B 5HAGBATBECHCYDEDKESFIFRGRIEITLILUMCNLPTSESI2006033020120620201225